Each Tuesday, we reverse-engineer a real SaaS company's revenue, profit, CAC, funnels, and its top growth tactic.
Sign up to access all features
Sign up with GoogleSign up with LinkedInAlready have an account? Log in
GetLatka is trusted by 200k+ founders, researchers, and marketers.
No contracts, cancel at any time
Developer of a digital healthcare platform intended to advance digital health to enhance the lives of patients. The company's platform offers to build workflows that automate and coordinate interactions between patients and their care teams, enabling organizations to combine assessment, patient-reported outcome and complication surveys with personalized recorded video and remote monitoring capabilities.
Last updated
In 2024, ViiMed's revenue reached $3.3M. The company previously reported $2.4M in 2023. Since its launch in 2007, ViiMed has shown consistent revenue growth.
ViiMed is a bootstrapped Generative AI Software startup. Founded in 2007, ViiMed has grown to $3.3M in revenue without raising any venture capital or outside funding.
As a self-funded Generative AI Software SaaS company, ViiMed has built its business with no outside investment.
| Year | Round | Amount | Valuation | % Sold | Source |
|---|
CEO
Phil Newman is the CEO, CPO, and Founder of ViiMed. Experienced healthcare executive. Customer centric. Experienced in product management and enterprise platform design. Focused on building platform technologies that are differentiated and meet many problems in the industry. Well-versed in investment strategies and business development. A strong, self-starter and entrepreneur.
| Question | Answer |
|---|---|
| What's your age? | - |
| Favorite online tool? | - |
| Favorite book? | - |
| Favorite CEO? | - |
| Advice for 20 year old self | - |
We do not have customer count information for ViiMed yet.
ViiMed employs approximately 25 people as of 2026, down from 41 in 2023, including 1 sales reps that carry a quota.
ViiMed generates an estimated $3.3M in annual revenue.
ViiMed was founded by Phil Newman.
The CEO of ViiMed is Phil Newman.
ViiMed is bootstrapped and has not raised outside funding.
ViiMed has 25 employees.
ViiMed is headquartered in Washington, District of Columbia, United States.
ViiMed operates across multiple industries. Browse revenue, funding, and growth data for ViiMed in each sector below.
All figures on this page are taken directly from interviews or are estimates from public sources and proprietary models. Not financial advice. Read full disclaimer.
Claim this profile
Networkable Operating System (ERP) for Manufacturing
B2B SaaS powered by AI that makes crop predictions (best harvesting time, plant diseases...)...
Developer of a hotel revenue management software designed to maximize hotel revenue. The company's...
Developer of a procurement platform for government and enterprise in Australia and overseas. The...
2024 Revenue
$3.3M(Est.)
Funding
$0
Team
25
Founded
2007
| Year | Milestone | Source |
|---|---|---|
| 2024 | ViiMed Hit $3.3m revenue in October 2024 | Estimated |
| 2023 | ViiMed Hit $2.4m revenue in December 2023 | Estimated |
| 2021 | ViiMed Hit $1.3m revenue in April 2021 | |
| 2007 | Launched with $0 revenue |
| Year | Milestone | Source |
|---|---|---|
| 2024 | Reached 25 employees (October 2024) | |
| 2023 | Reached 41 employees (December 2023) | |
| 2022 | Reached 42 employees (December 2022) | |
| 2021 | Reached 26 employees (December 2021) | |
| 2021 | Reached 15 employees (April 2021) |
If you're the CEO and would like to join the podcast, please DM Nathan Latka on LinkedIn.
